Inductive Bio integrates AI for drug development with Anthropic Claude
Inductive Bio has launched a new connection that integrates its ADMET prediction models for drug development with the AI assistant Anthropic Claude.
Vad har hänt
Biotechnology company Inductive Bio has launched a new connection, termed the MCP Connector, making its AI-driven ADMET prediction models available via Anthropic Claude. This integration allows researchers to utilise the Claude interface to analyse the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of potential drug candidates.
Key facts
| Företag | Inductive Bio |
|---|---|
| AI-plattform | Anthropic Claude |
| Funktion | ADMET-prediktion |
”Inductive Bio Brings AI-Powered ADMET Prediction Models to Claude via New MCP Connector”
Varför det spelar roll
By integrating these complex computational models directly into a conversational AI platform like Claude, the barrier for researchers to rapidly evaluate drug candidates is lowered. This could potentially accelerate the time-consuming and costly process of early drug development by identifying problematic compounds sooner.
Vem påverkas
The primary impact is on researchers and developers within the pharmaceutical industry working on early discovery and optimisation of drug candidates. Anthropic, the developer of Claude, also benefits by expanding the functionality of its AI assistant through third-party connections.
EU-status
Ej relevant för EU-status.
Mer att veta
The integration aims to streamline the process of testing drug compounds before they proceed to more expensive and resource-intensive laboratory tests.
Quick answers about this story
Vad har hänt?
När hände det?
Varför spelar det roll?
Vilka bolag berörs?
Länken öppnar i nytt fönster och leder till utgivarens egen sida.
Källan har spårats automatiskt från utgivaren via Aheadlines signalkedja.